Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 1415  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
Read this article

 


    Article Cited by others

SYMPOSIUM

Recent understanding in the treatment of visceral leishmaniasis.

Rosenthal E, Marty P

Year : 2003| Volume: 49| Issue : 1 | Page no: 61-8

   This article has been cited by
 
1 Gibbilimbol analogues as antiparasitic agents—Synthesis and biological activity against Trypanosoma cruzi and Leishmania (L.) infantum
Marina T. Varela,Roberto Z. Dias,Ligia F. Martins,Daiane D. Ferreira,Andre G. Tempone,Anderson K. Ueno,João Henrique G. Lago,João Paulo S. Fernandes
Bioorganic & Medicinal Chemistry Letters. 2016; 26(4): 1180
[Pubmed]  [Google Scholar] [DOI]
2 Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes
Ademar de Mesquita Barbosa,Solange dos Santos Costa,Josmar Rodrigues da Rocha,Carlos Alberto Montanari,Selma Giorgio
Biomedicine & Pharmacotherapy. 2015; 74: 95
[Pubmed]  [Google Scholar] [DOI]
3 A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies
Muzamil Yaqub Want,Mohammad Islamuddin,Garima Chouhan,Anjan Kumar Dasgupta,Asoke Prasun Chattopadhyay,Farhat Afrin
Journal of Colloid and Interface Science. 2014; 432: 258
[Pubmed]  [Google Scholar] [DOI]
4 Antileishmanial activity evaluation of adunchalcone, a new prenylated dihydrochalcone from Piper aduncum L.
Camilla R. Dal Picolo,Mariana P. Bezerra,Kaio S. Gomes,Luiz Felipe D. Passero,Marcia D. Laurenti,Euder Glendes A. Martins,Patricia Sartorelli,João Henrique G. Lago
Fitoterapia. 2014; 97: 28
[Pubmed]  [Google Scholar] [DOI]
5 Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences
Katerina Juzlova,Jana Votrubova,Denisa Kacerovska,Milan Lukas,Martin Bortlik,Hana Rohacova,Eva Nohynkova,Nadezda Vojackova,Jorga Fialova,Jana Hercogova
Dermatologic Therapy. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
6 In Vitro and In Vivo Studies of Antileishmanial Effect of Artemether on Leishmania infantum
Nahid Mortazavi Dehkordi,Fatemeh Ghaffarifar,Zuhair Mohammad Hassan,Farzad Esavand Heydari
Jundishapur Journal of Microbiology. 2013; 6(5)
[Pubmed]  [Google Scholar] [DOI]
7 Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis
Tejinder Kaur, Prerna Makkar, Kulbir Randhawa, Sukhbir Kaur
Parasitology Research. 2013; 112(1): 91
[HTML Full text]  [Google Scholar] [DOI]
8 Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh
Megha Raj Banjara,Siddhivinayak Hirve,Niyamat Ali Siddiqui,Narendra Kumar,Sangeeta Kansal,M. Mamun Huda,Pradeep Das,Suman Rijal,Chitra Kumar Gurung,Paritosh Malaviya,Byron Arana,Axel Kroeger,Dinesh Mondal
Journal of Tropical Medicine. 2012; 2012: 1
[Pubmed]  [Google Scholar] [DOI]
9 3-Trifluoromethylquinoxaline <i>N</i>,<i>N</i>′-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-<i>T. cruzi</i> Agents and Mechanism of Action Studies
Journal of Medicinal Chemistry. 2011; 54(10): 3624
[HTML Full text]  [Google Scholar] [DOI]
10 Traitement des leishmanioses en France : proposition d’un référentiel consensuel
Pierre A. Buffet,Éric Rosenthal,Jean-Pierre Gangneux,Edward Lightburne,Pierre Couppié,Gloria Morizot,Laurence Lachaud,Pierre Marty,Jean-Pierre Dedet
La Presse Médicale. 2011; 40(2): 173
[Pubmed]  [Google Scholar] [DOI]
11 Protective Therapy with Novel Chromone Derivative against Leishmania donovani Infection Induces Th1 Response in vivo
Suvadip Mallick,Aritri Dutta,Joydip Ghosh,Sourav Maiti,Ajay Kumar Mandal,Rajat Banerjee,Chandrakanta Bandyopadhyay,Chiranjib Pal
Chemotherapy. 2011; 57(5): 388
[Pubmed]  [Google Scholar] [DOI]
12 Drug delivery strategies for therapy of visceral leishmaniasis
Swati Gupta,Ajay Pal,Suresh P Vyas
Expert Opinion on Drug Delivery. 2010; 7(3): 371
[Pubmed]  [Google Scholar] [DOI]
13 Drug delivery strategies for therapy of visceral leishmaniasis
Gupta, S., Pal, A., Vyas, S.P.
Expert Opinion on Drug Delivery. 2010; 7(3): 371-402
[Pubmed]  [Google Scholar]
14 A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
Das, V.N.R., Siddiqui, N.A., Pandey, K., Singh, V.P., Topno, R.K., Singh, D., Verma, R.B.,Das, P.
Therapeutics and Clinical Risk Management. 2009; 5(1): 117-124
[Pubmed]  [Google Scholar]
15 Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: Synthesis, biological evaluation, and mode of action studies
Boiani, M., Boiani, L., Merlino, A., Hernández, P., Chidichimo, A., Cazzulo, J.J., Cerecetto, H., González, M.
European Journal of Medicinal Chemistry. 2009; 44(11): 4426-4433
[Pubmed]  [Google Scholar]
16 Copper (II) complexes of [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potential anti-parasitic agents
Boutaleb-Charki, S., Marín, C., Maldonado, C.R., Rosales, M.J., Urbano, J., Guitierrez-Sánchez, R., Quirós, M.,Sánchez-Moreno, M.
Drug Metabolism Letters. 2009; 3(1): 35-44
[Pubmed]  [Google Scholar]
17 Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009 | [Le traitement de la leishmaniose viscérale en Europe en 2009. Place de læamphotéricine B liposomale]
Rosenthal, E., Delaunay, P., Jeandel, P.-Y., Haas, H., Pomares-Estran, C., Marty, P.
Medecine et Maladies Infectieuses. 2009; 39(10): 741-744
[Pubmed]  [Google Scholar]
18 Le traitement de la leishmaniose viscérale en Europe en 2009. Place de l’amphotéricine B liposomale
E. Rosenthal,P. Delaunay,P.-Y. Jeandel,H. Haas,C. Pomares-Estran,P. Marty
Médecine et Maladies Infectieuses. 2009; 39(10): 741
[Pubmed]  [Google Scholar] [DOI]
19 Anti-trypanosomatid benzofuroxans and deoxygenated analogues: Synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies
Diego Castro, Lucia Boiani, Diego Benitez, Paola Hernández, Alicia Merlino, Carmen Gil, Claudio Olea-Azar, Mercedes González, Hugo Cerecetto, Williams Porcal
European Journal of Medicinal Chemistry. 2009; 44(12): 5055
[HTML Full text]  [Google Scholar] [DOI]
20 Oro-Pharyngeal Mass in a Patient With HIV Infection
Luis Mérida Rodrigo, Julián Olalla Sierra, Alfonso del Arco Jiménez, Isabel Rodrigo Fernández
Acta Otorrinolaringologica (English Edition). 2008; 59(4): 202
[HTML Full text]  [Google Scholar] [DOI]
21 Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: Mechanism of action studies
Luci´a Boiani,Gabriela Aguirre,Mercedes González,Hugo Cerecetto,Agustina Chidichimo,Juan J. Cazzulo,Massimo Bertinaria,Stefano Guglielmo
Bioorganic & Medicinal Chemistry. 2008; 16(17): 7900
[Pubmed]  [Google Scholar] [DOI]
22 Leishmaniasis: Drug resistance and natural products (review)
Polonio, T., Efferth, T.
International Journal of Molecular Medicine. 2008; 22(3): 277-286
[Pubmed]  [Google Scholar]
23 Oro-pharyngeal mass in a patient with HIV infection | [Masa orofaríngea en paciente con infección por VIH]
Mérida Rodrigo, L., Sierra, J.O., Jiménez, A.D.A., Fernández, I.R.
Acta Otorrinolaringologica Espanola. 2008; 59(4): 202-203
[Pubmed]  [Google Scholar]
24 Targeting glycoproteins or glycolipids and their metabolic pathways for antiparasite therapy
Mandal, C., Nee Bandyopadhyay, S.M.
Advances in Experimental Medicine and Biology. 2008; 625: 87-102
[Pubmed]  [Google Scholar]
25 Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: Mechanism of action studies
Boiani, L., Aguirre, G., González, M., Cerecetto, H., Chidichimo, A., Cazzulo, J.J., Bertinaria, M., Guglielmo, S.
Bioorganic and Medicinal Chemistry. 2008; 16(17): 7900-7907
[Pubmed]  [Google Scholar]
26 Mitochondrion of protozoan parasite emerges as potent therapeutic target: Exciting drugs are on the horizon
Sen, N., Majumder, H.K.
Current Pharmaceutical Design. 2008; 14(9): 839-846
[Pubmed]  [Google Scholar]
27 Masa orofaríngea en paciente con infección por VIH
Luis Mérida Rodrigo, Julián Olalla Sierra, Alfonso del Arco Jiménez, Isabel Rodrigo Fernández
Acta Otorrinolaringológica Española. 2008; 59(4): 202
[HTML Full text]  [Google Scholar] [DOI]
28 Injectable paromomycin for visceral leishmaniasis in India
Sundar, S., Jha, T.K., Thakur, C.P., Sinha, P.K., Bhattacharya, S.K.
New England Journal of Medicine. 2007; 356(25): 2571-2581
[Pubmed]  [Google Scholar]
29 IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: The significance of amphotericin B in the control of Leishmania donovani infection in India
Saha S, Mondal S, Ravindran R, et al.
JOURNAL OF IMMUNOLOGY. 2007; 179 (8): 5592-5603
[Pubmed]  [Google Scholar]
30 Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors
Granthon AC, Braga MV, Rodrigues JCF, et al.
VETERINARY PARASITOLOGY. 2007; 146 (1-2): 25-34
[Pubmed]  [Google Scholar]
31 Leishmaniasis (Reprinted from vol 82, pg 649-657, 2006)
Piscopo TV, Azzopardi CM
POSTGRADUATE MEDICAL JOURNAL. 2007; 83 (976): 649-657
[Pubmed]  [Google Scholar]
32 Injectable Paromomycin for Visceral Leishmaniasis in India
Shyam Sundar,T.K. Jha,Chandreshwar P. Thakur,Prabhat K. Sinha,Sujit K. Bhattacharya
New England Journal of Medicine. 2007; 356(25): 2571
[Pubmed]  [Google Scholar] [DOI]
33 Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors
Ana Claudia Granthon,Marina V. Braga,Juliany C.F. Rodrigues,Simon Cammerer,Silvia Orenes Lorente,Ian H. Gilbert,Julio A. Urbina,Wanderley de Souza
Veterinary Parasitology. 2007; 146(1-2): 25
[Pubmed]  [Google Scholar] [DOI]
34 An intracellular calcium store is present in Leishmania donovani glycosomes
Shreedhara Gupta,Bikramjit Raychaudhury,Shouvik Banerjee,Banasri Das,Salil C. Datta
Experimental Parasitology. 2006; 113(3): 161
[Pubmed]  [Google Scholar] [DOI]
35 Leishmania/HIV co-infections in the second decade
Cruz, I., Nieto, J., Moreno, J., Cañavate, C., Desjeux, P., Alvar, J.
Indian Journal of Medical Research. 2006; 123(3): 357-388
[Pubmed]  [Google Scholar]
36 Interferon gamma unresponsiveness due to down-regulation of IFN-R expression in experimental cutaneous leishmaniasis
Kariminia, A., Ardestani, S.K., Ardestani, N.A.-S., Sepehry, H., Darabi, H.
Iranian Biomedical Journal. 2006; 10(2): 105-109
[Pubmed]  [Google Scholar]
37 Leishmaniasis
Piscopo TV, Mallia AC
POSTGRADUATE MEDICAL JOURNAL. 2006; 82 (972): 649-657
[Pubmed]  [Google Scholar]
38 An intracellular calcium store is present in Leishmania donovani glycosomes
Gupta S, Raychaudhury B, Banerjee S, et al.
EXPERIMENTAL PARASITOLOGY. 2006; 113 (3): 161-167
[Pubmed]  [Google Scholar]
39 2H-benzimidazole 1,3-dioxide derivatives: A new family of water-soluble anti-trypanosomatid agents
Boiani M, Boiani L, Denicola A, et al.
JOURNAL OF MEDICINAL CHEMISTRY. 2006; 49 (11): 3215-3224
[Pubmed]  [Google Scholar]
40 Syntheses of new substituted triazino tetrahydroisoquinolines and β-carbolines as novel antileishmanial agents
Kumar, A., Katiyar, S.B., Gupta, S., Chauhan, P.M.S.
European Journal of Medicinal Chemistry. 2006; 41(1): 106-113
[Pubmed]  [Google Scholar]
41 Apoptosis in Leishmania species & its relevance to disease pathogenesis
Shaha, C.
Indian Journal of Medical Research. 2006; 123(3): 233-244
[Pubmed]  [Google Scholar]
42 Synthesis and in vitro antileishmanial activity of 5-substituted-2′- deoxyuridine derivatives
Peyron, C., Benhida, R., Bories, C., Loiseau, P.M.
Bioorganic Chemistry. 2005; 33(6): 439-447
[Pubmed]  [Google Scholar]
43 Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
Pasquau F, Ena J, Sanchez R, Cuadrado JM, Amador C, Flores J, Benito C, Redondo C, Lacruz J, Abril V, Onofre J
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2005; 24 (6): 411-418
[Pubmed]  [Google Scholar]
44 Imported leishmaniasis in Germany 2001–2004: data of the SIMPID surveillance network
T. Weitzel,N. Mühlberger,T. Jelinek,M. Schunk,S. Ehrhardt,C. Bogdan,K. Arasteh,T. Schneider,W. V. Kern,G. Fätkenheuer,G. Boecken,T. Zoller,M. Probst,M. Peters,T. Weinke,S. Gfrörer,H. Klinker,M.-L. Holthoff-Stich
European Journal of Clinical Microbiology & Infectious Diseases. 2005; 24(7): 471
[Pubmed]  [Google Scholar] [DOI]
45 Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives
Corinne Peyron,Rachid Benhida,Christian Bories,Philippe M. Loiseau
Bioorganic Chemistry. 2005; 33(6): 439
[Pubmed]  [Google Scholar] [DOI]
46 Leishmania-host interplay: The everlasting rivalry
Martiny, A., Vannier-Santos, M.A.
Medicinal Chemistry Reviews - Online. 2005; 2(3): 231-249
[Pubmed]  [Google Scholar]
47 Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network
Weitzel T, Muhlberger N, Jelinek T, et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2005; 24 (7): 471-476
[Pubmed]  [Google Scholar]
48 Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
F. Pasquau,J. Ena,R. Sanchez,J. M. Cuadrado,C. Amador,J. Flores,C. Benito,C. Redondo,J. Lacruz,V. Abril,J. Onofre
European Journal of Clinical Microbiology & Infectious Diseases. 2005; 24(6): 411
[Pubmed]  [Google Scholar] [DOI]
49 Isolation of Leishmania glycosomes by a rapid method
Raychaudhury B, Gupta S, Banerjee S, et al.
ANALYTICAL BIOCHEMISTRY. 2004; 332 (2): 404-408
[Pubmed]  [Google Scholar]
50 Isolation of Leishmania glycosomes by a rapid method
Bikramjit Raychaudhury,Shreedhara Gupta,Shouvik Banerjee,Banasri Das,Salil C. Datta
Analytical Biochemistry. 2004; 332(2): 404
[Pubmed]  [Google Scholar] [DOI]
51 Visceral leishmaniasis: A trip to the Greek Islands is not always idyllic
Ju, O., Grove, D.I., Jaksic, W.J., Dart, G.W.
Medical Journal of Australia. 2004; 181(8): 446-447
[Pubmed]  [Google Scholar]
52 In vitro assays for evaluation of drug activity against Leishmania spp.
Luciana Fumarola,Rosa Spinelli,Olga Brandonisio
Research in Microbiology. 2004; 155(4): 224
[Pubmed]  [Google Scholar] [DOI]
53 Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection
H. Sindermann,K. R. Engel,C. Fischer,W. Bommer
Clinical Infectious Diseases. 2004; 39(10): 1520
[Pubmed]  [Google Scholar] [DOI]
54 Challenges and new discoveries in the treatment of leishmaniasis
Singh, S., Sivakumar, R.
Journal of Infection and Chemotherapy. 2004; 10(6): 307-315
[Pubmed]  [Google Scholar]
55 Visceral leishmaniases
Rosenthal, É., Marty, P.
Revue du Praticien. 2004; 54(20): 2211-2216
[Pubmed]  [Google Scholar]
56 Challenges and new discoveries in the treatment of leishmaniasis
Sarman Singh,Ramu Sivakumar
Journal of Infection and Chemotherapy. 2004; 10(6): 307
[Pubmed]  [Google Scholar] [DOI]
57 In vitro assays for evaluation of drug activity against Leishmania spp.
Fumarola L, Spinelli R, Brandonisio O
Research in Microbiology. 2004; 155 (4): 224-230
[Pubmed]  [Google Scholar]
58 Oral miltefosine for leishmaniasis in immunocompromised patients: Compassionate use in 39 patients with HIV infection
Sindermann, H., Engel, K.R., Fischer, C., Bommer, W.
Clinical Infectious Diseases. 2004; 39(10): 1520-1523
[Pubmed]  [Google Scholar]
59 Leishmania - From the bite to the disease
Cebalo, L.
Infektoloski Glasnik. 2003; 23(4): 197-204
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow